Lca-vision Inc: (NASD: LCAV)

$3.44

0.06 (1.78%)

Volume 7,432

May 17 04:00 PM ET

Zacks Rank: 4-Sell

 
 
 
#4
 

Overview Quote

Get Overview Quote for:

Stock Activity

Day Low - High 3.39 - 3.55
52wk Low - High 2.67 - 6.19
Previous Close 3.38
Avg. Volume 52,359
Industry MED-OUTP/HM CRE
Market Cap 65.54 M
Div - Yield 0.00 - 0.00
Beta 3.07
PE (Forward) 0.00
Current Year Est. -0.31
Quarterly Earnings ESP -41.67%

Premium research

Zacks Rank Short-Term: 1-3 Months

Zacks #1 Rank Strong Buys

4

Zacks Recommendation Long-Term: 6+ Months

All Outperform Rated Stocks

Neutral

Zacks Industry Rank

201 out of 265

Equity Research Report

Updated as of 05/14/2013

PREMIUM

( = Change in last 30 days)

Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial

Key Earnings Data

PE (Forward) NA
PEG Ratio NA
Current Year Est. -0.31
Current Quarter Estimate -0.12
Most Accurate Estimate -0.17
Earnings ESP -41.67%
Next Earnings Report Date 08-06-2013
EPS Last Year -0.53
Expected Earnings Growth NA

Company Description

LCA-Vision Inc. provides laser vision correction at affordable prices.

NYSE data is at least 20 minutes delayed.

NASDAQ data is at least 15 minutes delayed.

Interactive Java Charting | Fundamental Charts

Introducing Zacks Whisper Trader

Turn Earnings Surprises into quick profits.

 

LCAV Chart by YCharts

Earnings Estimates

Current Qtr
(06/2013)
Next Qtr
(09/2013)
Current Year
(12/2013)
Next Year
(12/2014)
Average Estimate -0.12 -0.16 -0.31 -0.19
Number of Estimates 2 2 2 2
Low Estimate -0.17 -0.20 -0.51 -0.42
High Estimate -0.06 -0.11 -0.11 NA
Year Ago EPS -0.17 -0.19 -0.39 -0.31
EPS Growth 32.35% 18.42% 20.51% 37.10%

Average Earnings Estimates for LCAV

EPS Growth for LCAV

Industry Analysis

Name Symbol Previous Close Zacks Rank Zacks Recommendation
LCA-VISION INC LCAV 3.44
ADDUS HOMECARE ADUS 15.37
HEALTHSOUTH CP HLS 30.36
AMSURG CORP AMSG 36.38
BRAIN RESOURCE BRRZY 0.00
CHINA CORD BLD CO 2.82
DAVITA INC DVA 128.14
LHC GROUP LLC LHCG 22.56
QUEST DIAGNOSTC DGX 60.69
RADNET INC RDNT 2.54

Sector:Medical>> Industry:MED-OUTP/HM CRE

COMPARE TICKER vs. Its Peers

Financials

EPS TTM -0.53
Sales 101
Net Income -11
Price/Earnings NA
Price/Book 3.12
Price/Cash Flow NA
Price/Sales 0.70

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.